Related references
Note: Only part of the references are listed.Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: Expert clinical opinion
Gerhard Rogler et al.
JOURNAL OF CROHNS & COLITIS (2013)
Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents
Pauliina Molander et al.
INFLAMMATORY BOWEL DISEASES (2012)
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naive patients with ulcerative colitis
M. De Vos et al.
JOURNAL OF CROHNS & COLITIS (2012)
Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers
Petr Ricanek et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis
G. T. Ho et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Ulcerative Colitis: Correlation of the Rachmilewitz Endoscopic Activity Index with Fecal Calprotectin, Clinical Activity, C-reactive Protein, and Blood Leukocytes
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2009)
Fecal Calprotectin and Lactoferrin for the Prediction of Inflammatory Bowel Disease Relapse
Javier P. Gisbert et al.
INFLAMMATORY BOWEL DISEASES (2009)
Can calprotectin predict relapse risk in inflammatory bowel disease?
Renata D'Inca et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Colectomy rate in acute severe ulcerative colitis in the infliximab era
A. Aratari et al.
DIGESTIVE AND LIVER DISEASE (2008)
Accuracy of four fecal assays in the diagnosis of colitis
Alain M. Schoepfer et al.
DISEASES OF THE COLON & RECTUM (2007)
Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease
Renata D'Inca et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)
Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease
Kaija-Leena Kolho et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease
Michael R. Konikoff et al.
INFLAMMATORY BOWEL DISEASES (2006)
Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease
AG Roseth et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)